Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04020913 · ClinicalTrials.gov registry record
Skeletal Muscle Effects of GH in Boys
A clinical trial, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 45
- Enrollment target
NCT04020913 is a clinical trial that has completed, run by Nemours Children's Clinic. The registered enrollment target is 45 participants.
The verdict
NCT04020913 has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of the study is to measure the functional effects of recombinant GH in skeletal muscle, in addition to growth promotion, in short prepubertal boys with either growth hormone deficiency or idiopathic short stature. Patients will be similarly short. The investigators will also compare these values in the short stature cohort to those obtained in testing performed in normally growing age-matched healthy control boys not on GH. The group on GH will be studied before and after 6 and 12 months of GH treatment.
Interventions
- DRUG Somatropin injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2025-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04020913
The ClinicalTrials.gov registry entry for NCT04020913 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Somatropin injection is the first listed.
NCT04020913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04020913 about?
NCT04020913 is a clinical study titled "Skeletal Muscle Effects of GH in Boys". The purpose of the study is to measure the functional effects of recombinant GH in skeletal muscle, in addition to growth promotion, in short prepubertal boys with either growth hormone deficiency or idiopathic short stature. Patients will be similarly short. The investigators will also compare thes...
What is the current status of trial NCT04020913?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2019-07-22. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT04020913?
The interventions under investigation include: Somatropin injection (DRUG).
Who is sponsoring clinical trial NCT04020913?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.